mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.002 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.002 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.002 |